Literature DB >> 2802806

Evaluating drugs in rheumatoid arthritis.

A Larsen.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2802806      PMCID： PMC1003879          DOI： 10.1136/ard.48.9.790

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  What should we hope to achieve when treating rheumatoid arthritis?

Authors:  D L Scott; T D Spector; T Pullar; B McConkey
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

2.  The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.

Authors:  B McConkey; R A Crockson; A P Crockson; A R Wilkinson
Journal:  Q J Med       Date:  1973-10

3.  Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

Authors:  G Borg; E Allander; B Lund; E Berg; U Brodin; H Pettersson; L Trang
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

4.  Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study.

Authors:  D M Nordstrom; S G West; P A Andersen; J T Sharp
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391
  4 in total
  1 in total

1.  Assessment of rheumatoid arthritis.

Authors:  B McConkey
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.